IL10 and non-small cell lung carcinoma: Thus, it could be demonstrated that NSCLC patients show significantly elevated IL-10 mRNA as well as serum levels as compared to healthy controls which has been shown to be associated with poorer prognosis (Hatanaka et al., 2000).